U.S. adoption continues to expand, with Vericel reporting NexoBrid’s highest quarterly revenue since launch, up 38% year-over-year and 26% sequentially. Vericel reported broad utilization across more ...
Lassila & Tikanoja plc Stock exchange release20 November 2025 at 4:30 p.m The Finnish Financial Supervisory Authority has approved Lassila & Tikanoja's demerger and listing prospectus; The New Lassila ...
Introduction Medication use during pregnancy is common, and socioeconomic disparities in access may contribute to maternal ...
In order to pay your employees correctly each pay period, you need to know how to calculate gross and net pay. Learn how to ...
LuxExperience B.V. (NYSE:LUXE) (the "Company"), today announced its financial results for its first quarter of fiscal year 2026 ended September 30, 2025. The leading luxury multi-brand digital ...
Veeva Systems Inc. , a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, ...
We reported results for the third fiscal quarter, 2025 with revenues, net of $9.7 million, Adjusted EBITDA of $4.2 million and net income per common share of $0.11. In comparison to 2024 market ...
Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx- in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid- Facility; Full Operational Capacity Expected by Year-End 2025 ...